X has spent nearly a year rebuilding its Android app from scratch, promising smoother scrolling, faster loading, more reliable notifications, and a stronger foundation for upcoming features.

Roll up, roll up for a High Court ruling, Alison Hammond and a Highgrove reconciliation. Our Deputy Royal Editor had a ...

Canada’s former prime minister appeared in the background of popstar Katy Perry’s TikTok video, promoting her latest single.

When I last chatted with Auliʻi Cravalho two years ago, it was to talk about her most famous character, Moana. Hopping on a Zoom call with her late last month, we were once again talking about the ...

Two Gay Matts share their thoughts and give a candid reaction and review of Lil Nas X's song and music video, J Christ. Watch what happens when a 5,000kg orca hits a boat – it doesn’t end well ...

Angelina Jolie is getting candid about her dating life. The Oscar-winning actress, 51, revealed in a recent interview with Yahoo Entertainment that she has not been in a romantic relationship since ...

In case you've faced some hurdles solving the clue, Candid view, we've got the answer for you. Crossword puzzles offer a fantastic opportunity to engage your mind, enjoy leisure time, and test your ...

This is read by an automated voice. Please report any issues or inconsistencies here. See more from the L.A. Times in Google Search. Set us as preferred Lil Nas X speaks openly about receiving ...

At an earlier point in his career, Lil Nas X was a lightning rod for attention — whether in the form of Number One singles or outraged controversy surrounding his visual output. But over the past year ...

Recalling the “Candid Camera” of yore, we can still remember the reactions from folks who had no idea they were being filmed. Allen Funt’s prescient reality TV show may be long gone from the airwaves, ...

Summit Therapeutics' closely watched PD-1xVEGF study surprisingly missed its mark at an interim analysis. UCB will pay $2 billion upfront to buy Candid Therapeutics, which has aggregated a group of ...

UCB researchers at work. UCB has agreed to acquire Candid Therapeutics for up-to-$2.2 billion, the companies said, in a deal designed to expand the buyer’s presence in T-cell engager (TCE) antibodies ...